The US Food and Drug Administration (FDA) has granted breakthrough device designation to PreludeDx's DCISionRT test, a risk ...

The US Food and Drug Administration (FDA) has approved Zeiss Medical Technology’s MEL 90 excimer laser technology.

Patients with HER-2 positive early breast cancer with residual invasive disease after neoadjuvant therapy were randomly ...

Childhood cancer survivors had greater than twofold increased risk of invasive skin and ocular melanoma (95% CI 1.6-2.4) ...

An FDA application for TAR-200 to treat BCG-unresponsive high-risk non-muscle-invasive bladder cancer is under real-time ...

While the absolute risk of melanoma by age 40 remained low, survivors of childhood cancer exhibited a standardized incidence ...

Share on Pinterest “Boy Meets World” actor Danielle Fishel recently completed treatment for a very early stage of breast cancer known as ductal carcinoma in situ (DCIS). Paul Archuleta/Getty ...

TransMedics' stock remains under pressure after a weak third quarter, reduced Q4 guidance, the exit of the company's CFO, and ...

The Society for Simulation in Healthcare (SSH) has announced that Jared Kutzin, DNP, MS, MPH, RN, CHSOS, FSSH, FAAN, has become the 20th President of the Society. His term began at the completion of ...

Artificial Intelligence: Algorithms Improve Medical Image Analysis Jan. 2, 2025 — Artificial intelligence has the potential to improve the analysis of medical image data. For example ...

In a report released today, Matt Hewitt from Craig-Hallum maintained a Buy rating on NeoGenomics (NEO – Research Report). The company’s shares ...